Hot flashes happened less often and were less severe in women who took elinzanetant compared to those who took a placebo. The ...

CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...

Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...

Instead, hot flash medication — an experimental drug called elinzanetant — doesn’t use hormones and has been shown to reduce hot flashes and improve sleep based on a study from the journal ...

A drug under development could provide a much needed option for women seeking relief from hot flashes and other menopausal symptoms, new research shows. The drug, elinzanetant, cut the frequency ...

A new era of menopause treatment looks to be on the horizon. This week, drugmaker Bayer published the results of two successful Phase III trials testing its experimental drug elinzanetant as a ...

If lifestyle changes and strategies don’t work, or if your case is severe, your doctor may prescribe medication to help you manage your hot flashes. Hot flashes can also be a side effect of ...

Overconsumption of caffeine, spicy foods, and heart and blood pressure medications have also been shown to trigger hot flashes in some people. When triggered by such medical conditions or ...

A new treatment for hot flashes brought relief and a better night’s rest for women experiencing these disruptive symptoms during menopause. Two phase 3 clinical trials compared the drug ...

The investigational drug elinzanetant reduces hot flashes while improving women's sleep and quality of life, new research finds. The investigational drug elinzanetant significantly reduces the ...

The FDA warned that fezolinetant (Veozah), a hormone-free pill for moderate to severe hot flashes caused by menopause ... or right upper quadrant pain. Treatment discontinuation may prevent ...